Hyperprolactinemia in postmenopausal women

Fertility and Sterility

Volumn 67, Issue 4, 1997, Pages 693-696

  Maor, Yasmin ^a   Berezin, Meir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

follicular stimulating hormone; luteinizing hormone; macroadenoma; microadenoma; Pituitary; postmenopause; prolactin

Indexed keywords

BROMOCRIPTINE; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN;

ADULT; AGED; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0030982883     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81368-4     Document Type: Article

References (17)

1. Koppelman MCS, Jaffe MJ, Rieth KG, Caruso RC, Loriaux L. Hyperprolactinemia, amenorrhea, and galactorrhea. Ann Intern Med 1984;100:115-21.
2. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 1989;68:412-8.
3. Berezin M, Shimon I, Hadani M. Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma). J Endocrinol Invest 1995;18:436-41.
4. Friesen HG, Tolis G. The use of bromocriptine in the galactorrhea-amenorrhea syndromes: the Canadian co-operative study. Clin Endocrinol (Oxf) 1977;6 Suppl:91S-9S.
5. Gomez F, Reyes FI, Faiman C. Nonpuerperal galactorrhea and hyperprolactinemia: clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med 1977;62:648-60.
6. March CM, Kletzky OA, Davajan V, Teal J, Weiss M, Apuzzo ML,et al. Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 1981;139:835-44.
7. Weiss MH, Teal J, Gott P, Wycoff R, Yadley R, Apuzzo ML, et al. Natural history of microprolactinomas: six-year follow-up. Neurosurgery 1983;12:180-3.
8. Sisam DA, Sheehan JP, Sheeler LR. The natural history of untreated microprolactinomas. Fertil Steril 1987;48:67-71.
9. Berezin M, Giladi Y. Hot flushes in postmenopausal hyperprolactinemic women. Isr J Obstet Gynecol 1993;4:173-8.
10. Scoccia B, Schneider AB, Marut EL, Scommegna A. Pathological hyperprolactinemia suppresses hot flushes in menopausal women. J Clin Endocrinol Metab 1988;66:868-71.
11. Blankstein J, Mashiach S, Lunenfeld B. Ovulation induction and in vitro fertilization. Chicago: Year Book Medical Publishers, 1986.
12. Quigley ME, Judd SJ, Gillil GB, Yen SSC. Effects of dopamine antagonists on the release of gonadotropins and prolactin in normal women and women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 1979;48:718-20.
13. MacLeod RM, Kimura H, Login I. Inhibition of prolactin secretion by dopamine and piribedit (ET-495). In: Pecile A, Uuller EE, editors. Growth hormone and related peptides. New York: Elsevier North-Holland, 1976:443-53.
14. Bevan JS, Webster J, Burke CW, Scanlon ME. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992;13:220-40.
15. Rasmussen DD, Liu JH, Wolf PL, Yen SSC. Gonadotropin-releasing hormone neurosecretion in the human hypothalamus: in vitro regulation by dopamine. J Clin Endocrinol Metab 1986;62:479-83.
16. Cox B, Lomax P. Pharmacologic control of temperature regulation. Annu Rev Pharmacol Toxicol 1977;17:341-49.
17. Moult PJA, Rees LH, Besser GM. Pulsatile gonadotropin secretion in hyperprolactinemic amenorrhea and the response to bromocriptine therapy. Clin Endocrinol (Oxf) 1982;16: 153-62.